Director of Investor Relations and Corporate Communications
Mr. Schepers has 20 years of investor relations and corporate communications experience in the healthcare industry, including specialty pharmaceuticals, generics, and biotechnology. He joins Pernix, following four years at Shionogi/Sciele Pharma, as Director of Investor Relations and Corporate Communications. Mr. Schepers has also served as Director of Investor Relations, North America, at Novartis, and Head of Investor Relations and Corporate Communications for ICN Pharmaceuticals/ Ribapharm, and Cryolife. Mr. Schepers holds a Bachelor’s degree in Communications and a Masters of Business Administration from Seton Hall University.
